Your browser doesn't support javascript.
loading
Ion transport blockers inhibit human rhinovirus 2 release.
Gazina, Elena V; Harrison, David N; Jefferies, Meryem; Tan, Heneu; Williams, David; Anderson, David A; Petrou, Steven.
Afiliação
  • Gazina EV; Howard Florey Institute, The University of Melbourne, Vic. 3010, Australia. gazina@hfi.unimelb.edu.au
Antiviral Res ; 67(2): 98-106, 2005 Aug.
Article em En | MEDLINE | ID: mdl-16054245
ABSTRACT
Picornavirus replication causes leakage of cytoplasmic K+ and an influx of Na+ and Ca2+. In this study, we have explored the possibility that a blockade of Ca2+ and Na+ influx would reduce rhinovirus production and/or release. The Ca2+-channel blockers, verapamil and diltiazem, as well as the blocker of Na+/H+ exchange and the epithelial Na+ channel, EIPA, inhibited both virus production and release. The effect on virus release was more pronounced than the effect on production, thus raising the possibility that rhinovirus release may serve as a target for antiviral agents. Unexpectedly, our results also showed that the antiviral activity of the Ca2+-channel blockers was not due to the block of Ca2+ influx. Similarly, the antiviral activity of EIPA appeared to be unrelated to the blockade of cellular Na+/H+ exchanger or the epithelial Na+ channel. Potential alternative mechanisms of the antiviral activity of these compounds are discussed.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Rhinovirus / Bloqueadores dos Canais de Cálcio / Transporte de Íons Limite: Humans Idioma: En Ano de publicação: 2005 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Rhinovirus / Bloqueadores dos Canais de Cálcio / Transporte de Íons Limite: Humans Idioma: En Ano de publicação: 2005 Tipo de documento: Article